Indo Us Bio-Tech Ltd Reconstitutes Board Committees Following Director Change

Indo Us Bio-Tech Ltd Reconstitutes Board Committees Following Director Change

Indo Us Bio-Tech Ltd Reconstitutes Board Committees Following Director Change​

Indo Us Bio-Tech Ltd announced changes in the composition of its various board committees following a meeting held on July 10, 2026. The move was necessitated by a senior director's resignation and the subsequent appointment of a new independent director.

The company's Board of Directors approved the reconstitution of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee during the meeting. These changes are effective as of July 10, 2026.

The necessity for committee changes arose from the resignation of Mrs. Nehaben Patel, who served as a Non-Executive Independent Director of the company. Following this departure, the Board appointed Mrs. Hemanshi Darsh Soni as an Additional Director (Non-Executive, Independent) on April 21, 2026, pending shareholder approval.

As part of the board's response to these changes, the structure and membership of the three key committees were revised.

Committee Composition Details

The members and roles for each committee are detailed below:

Audit Committee
Sr.No.NameDesignation
1.Ritaben Nileshbhai KikaniChairperson
2.Shilpa Chetanbhai ThumarMember
3.Jagdishkumar Devjibhai AjudiyaMember
4.Hemanshi Darsh SoniMember

Nomination and Remuneration Committee
Sr.No.NameDesignation
1.Shilpa Chetanbhai ThumarChairperson
2.Ritaben Nileshbhai KikaniMember
3.Hemanshi Darsh SoniMember

Stakeholders Relationship Committee
Sr.No.NameDesignation
1.Ritaben Nileshbhai KikaniChairperson
2.Jagdishkumar Devjibhai AjudiyaMember
3.Hemanshi Darsh SoniMember
4.Shilpa Chetanbhai ThumarMember

The board meeting related to this outcome commenced at 15:00 P.M. and concluded at 15:30 P.M.

INDOUS Stock Price Movement​

Indo Us Biotech Limited shares slipped by 1.79% today, settling at ₹87.52 in post-market trading. The stock closed after trading a total of 18,003 shares during the session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:

Editorial Note

This news article was written and created by Himanshu, and published on IST.
Back
Top